Clik here to view.
Triplebar and Umami Meats Initiate Technology Collaboration To Optimize Cell...
EMERYVILLE, Calif. & SINGAPORE Biotechnology company Triplebar and cultivated seafood platform company Umami Meats are partnering to co-develop optimized cell lines suitable for large-scale...
View ArticleClik here to view.
アレフ・ファームズがVBLセラピューティクスの施設買収とエスコ・アスターとの提携により生産能力を増強
イスラエル・レホボト （ビジネスワイヤ） — 非遺伝子組み換えウシ細胞から直接的に培養ステーキ肉を育てる初の企業であるアレフ・ファームズは本日、バイオテクノロジー企業のVBLセラピューティクス（Nasdaq:...
View ArticleClik here to view.
Biocytogen Announces RenLite™ Licensing Agreement with Janssen
BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) (HKEX: 02315), today announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen...
View ArticleClik here to view.
Clik here to view.
バイオサイトジェンがRenLite™に関するヤンセンとのライセンス契約を発表
北京 （ビジネスワイヤ） — バイオサイトジェン・ファーマシューティカルズ（北京）（以下「バイオサイトジェン」、HKEX:...
View ArticleClik here to view.
OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that it has received approval from the Human Research Ethics Committee...
View ArticleClik here to view.
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research...
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) announced today that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying...
View ArticleClik here to view.
Fujirebio expands its assay menu in the field of neurodegenerative diseases...
GENT, Belgium & MALVERN, Pa. & TOKYO H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood...
View ArticleClik here to view.
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK...
View ArticleClik here to view.
Thermo Fisher Scientific与Arsenal Biosciences合作，支持自体T细胞疗法的临床制造
加州卡尔斯班 (美国商业资讯)–服务科学领域的全球领先公司Thermo Fisher Scientific与面向实体瘤设计先进嵌合抗原受体(CAR)-T细胞疗法的临床阶段细胞治疗公司Arsenal Biosciences, Inc....
View ArticleClik here to view.
Clik here to view.
Agilent Announces Thought Leader Award to Dr. Chenli Liu
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Dr. Chenli Liu has been selected to receive an Agilent Thought Leader Award. The award will support his pioneering...
View ArticleClik here to view.
Clik here to view.
バイオサイトジェンがRenLite™に関するヤンセンとのライセンス契約を発表
北京 （ビジネスワイヤ） — バイオサイトジェン・ファーマシューティカルズ（北京）（以下「バイオサイトジェン」、HKEX:...
View ArticleClik here to view.
OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that it has received approval from the Human Research Ethics Committee...
View ArticleClik here to view.
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research...
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) announced today that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying...
View ArticleClik here to view.
Fujirebio expands its assay menu in the field of neurodegenerative diseases...
GENT, Belgium & MALVERN, Pa. & TOKYO H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood...
View ArticleClik here to view.
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK...
View ArticleClik here to view.
Thermo Fisher Scientific与Arsenal Biosciences合作，支持自体T细胞疗法的临床制造
加州卡尔斯班 (美国商业资讯)–服务科学领域的全球领先公司Thermo Fisher Scientific与面向实体瘤设计先进嵌合抗原受体(CAR)-T细胞疗法的临床阶段细胞治疗公司Arsenal Biosciences, Inc....
View ArticleClik here to view.